Menu

Northwest Biotherapeutics, Inc. NWBO

Full chart Compare
Set alert

Price alert · NWBO

All alert types
0.17 USD 0.00 (+0.78%)

Nov 11, 2026, 3:55 PM EST

0.1639 Day range 0.1684
0.14 52-week range 0.34
YTD
-26.78%
1 year
-29.83%

Revenue & Expenses

Other Operating Income → Expenses: $2.34MExpenses → Gross Loss: $959.00KExpenses → Selling, General & Admin: $32.51MExpenses → Research & Development: $28.79MExpenses → Other Expenses: $785.00KExpenses → Income Tax: $778.00KNet Loss → Expenses: $61.48MRevenue → Cost of Revenue: $1.38MOther Operating Income$2.34MNet Loss$61.48MCost of Revenue$2.34MExpenses$63.81MGross Loss$959.00KSelling, General & Admin$32.51MResearch & Development$28.79MOther Expenses$785.00KIncome Tax$778.00KRevenue$1.38M

Latest period ending Dec 31, 2024 · select a line to chart its full history

Annual income statement

NWBO annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
1.38M1.93M1.68M1.00M1.29M
1.38M1.93M1.68M1.00M1.29M
1.38M1.93M1.68M1.00M1.29M
67.89M57.44M68.86M53.71M87.90M
34.89M27.73M35.51M20.31M33.64M
33.00M29.71M33.35M33.40M54.26M
-66.51M-55.51M-67.18M-52.70M-86.61M
7.77M5.24M6.07M5.01M8.54M
-83.78M-62.60M-105.03M179.13M-529.82M
-85.19M-64.37M-105.03M179.13M-529.82M
-85.19M-64.37M-105.03M179.13M-529.82M
-83.78M-62.60M-105.03M179.13M-529.82M
-0.07-0.06-0.100.21-0.73
-0.07-0.06-0.100.21-0.73
-0.07-0.06-0.10-0.06-0.73
-76.01M-57.36M-98.96M184.14M-521.28M
-76.01M-57.36M-98.96M184.14M-521.28M
1.41M1.77M000
1.24B1.12B1.02B873.52M725.13M
1.24B1.12B1.02B1.01B725.13M